HEALTHCARE AI ACQUISITION CORP Financials

HAIAF

Source SEC Filings (10-K/10-Q) Updated Jun 30, 2025 Currency USD FYE December

This page shows HEALTHCARE AI ACQUISITION CORP (HAIAF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak

2/9

HEALTHCARE AI ACQUISITION CORP passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Low Quality

-7.85x

For every $1 of reported earnings, HEALTHCARE AI ACQUISITION CORP generates $-7.85 in operating cash flow (-$446K OCF vs $57K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

$57K

YoY-98.7%

HEALTHCARE AI ACQUISITION CORP reported $57K in net income in fiscal year 2024. This represents a decrease of 98.7% from the prior year.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$212

YoY+0.0%

HEALTHCARE AI ACQUISITION CORP held $212 in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

HEALTHCARE AI ACQUISITION CORP had 6M shares outstanding in fiscal year 2024.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

HAIAF Income Statement

Metric	FY24	FY23	FY22	FY21
Revenue	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A
Operating Income	-$671K+42.6%	-$1.2M+3.1%	-$1.2M+55.2%	-$2.7M
Interest Expense	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A
Net Income	$57K-98.7%	$4.3M-66.2%	$12.8M+19.4%	$10.7M
EPS (Diluted)	N/A	N/A	N/A	N/A

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$73K+3.8%	-$76K	N/A	-$413K-483.8%	-$71K+19.2%	-$88K	N/A	-$288K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$542K-631.3%	-$74K	N/A	-$8K-105.3%	$146K+131.2%	-$467K	N/A	$829K
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HAIAF Balance Sheet

Metric	FY24	FY23	FY22	FY21
Total Assets	$5.7M-14.1%	$6.6M-97.1%	$223.7M+0.2%	$223.2M
Current Assets	$995K+469059.0%	$212-100.0%	$624K-79.4%	$3.0M
Cash & Equivalents	$2120.0%	$212	$0	$0
Inventory	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A
Total Liabilities	$7.1M-8.7%	$7.7M-96.7%	$232.4M-3.8%	$241.6M
Current Liabilities	$2.3M+282.9%	$593K+280.9%	$156K-91.3%	$1.8M
Long-Term Debt	N/A	N/A	N/A	N/A
Total Equity	-$1.4M-22.2%	-$1.1M+86.9%	-$8.7M+52.6%	-$18.4M
Retained Earnings	-$1.6M+3.4%	-$1.7M+80.8%	-$8.7M+52.6%	-$18.4M

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$2.9M-50.3%	$5.8M+1.7%	$5.7M-17.4%	$6.8M+0.8%	$6.8M+0.8%	$6.7M+2.2%	$6.6M+0.8%	$6.5M
Current Assets	$995K0.0%	$995K0.0%	$995K+4760.8%	$20K-49.7%	$41K-33.2%	$61K+28655.7%	$212-98.9%	$19K
Cash & Equivalents	$2120.0%	$2120.0%	$2120.0%	$2120.0%	$2120.0%	$2120.0%	$2120.0%	$212
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.0M-31.3%	$7.3M+3.7%	$7.1M-17.5%	$8.6M+1.7%	$8.4M-0.2%	$8.4M+9.0%	$7.7M-2.2%	$7.9M
Current Liabilities	$2.5M+4.3%	$2.4M+5.7%	$2.3M+91.7%	$1.2M+49.6%	$792K+6.8%	$742K+25.0%	$593K+37.9%	$430K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.2M-38.2%	-$1.6M-12.0%	-$1.4M+18.2%	-$1.7M-5.2%	-$1.6M+4.1%	-$1.7M-48.2%	-$1.1M+16.7%	-$1.4M
Retained Earnings	-$2.2M-32.1%	-$1.7M-4.6%	-$1.6M+19.3%	-$2.0M-0.4%	-$2.0M+6.8%	-$2.1M-27.9%	-$1.7M+12.1%	-$1.9M

HAIAF Cash Flow Statement

Metric	FY24	FY23	FY22	FY21
Operating Cash Flow	-$446K-11.2%	-$401K+78.3%	-$1.9M+28.2%	-$2.6M
Capital Expenditures	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	-$219.9M
Financing Cash Flow	$446K	$0+100.0%	-$247K-100.1%	$225.0M
Dividends Paid	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$48K+52.2%	-$100K+18.4%	-$123K-3.0%	-$119K+41.7%	-$204K	$0	$0	$0
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$48K-52.2%	$100K-18.4%	$123K+3.0%	$119K-41.7%	$204K	$0	$0	$0
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HAIAF Financial Ratios

Metric	FY24	FY23	FY22	FY21
Gross Margin	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A
Return on Assets	1.0%-64.7pp	65.7%+60.0pp	5.7%+0.9pp	4.8%
Current Ratio	0.44+0.4	0.00-4.0	4.01+2.3	1.69
Debt-to-Equity	-5.04+1.7	-6.75+19.9	-26.68-13.5	-13.13
FCF Margin	N/A	N/A	N/A	N/A

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-18.9%-17.7pp	-1.3%	N/A	-0.1%-2.3pp	2.1%+9.1pp	-6.9%	N/A	12.7%
Current Ratio	0.40-0.0	0.41-0.0	0.44+0.4	0.02-0.0	0.05-0.0	0.08+0.1	0.00-0.0	0.05
Debt-to-Equity	-2.32+2.3	-4.67+0.4	-5.04-0.0	-5.00+0.2	-5.17-0.2	-4.97+1.8	-6.75-1.0	-5.75
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$1.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.44), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is HEALTHCARE AI ACQUISITION CORP profitable?

Yes, HEALTHCARE AI ACQUISITION CORP (HAIAF) reported a net income of $57K in fiscal year 2024.

What is HEALTHCARE AI ACQUISITION CORP's operating cash flow?

HEALTHCARE AI ACQUISITION CORP (HAIAF) generated -$446K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are HEALTHCARE AI ACQUISITION CORP's total assets?

HEALTHCARE AI ACQUISITION CORP (HAIAF) had $5.7M in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does HEALTHCARE AI ACQUISITION CORP have outstanding?

HEALTHCARE AI ACQUISITION CORP (HAIAF) had 6M shares outstanding as of fiscal year 2024.

What is HEALTHCARE AI ACQUISITION CORP's current ratio?

HEALTHCARE AI ACQUISITION CORP (HAIAF) had a current ratio of 0.44 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is HEALTHCARE AI ACQUISITION CORP's debt-to-equity ratio?

HEALTHCARE AI ACQUISITION CORP (HAIAF) had a debt-to-equity ratio of -5.04 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is HEALTHCARE AI ACQUISITION CORP's return on assets (ROA)?

HEALTHCARE AI ACQUISITION CORP (HAIAF) had a return on assets of 1.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is HEALTHCARE AI ACQUISITION CORP's cash runway?

Based on fiscal year 2024 data, HEALTHCARE AI ACQUISITION CORP (HAIAF) had $212 in cash against an annual operating cash burn of $446K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is HEALTHCARE AI ACQUISITION CORP's debt-to-equity ratio negative or unusual?

HEALTHCARE AI ACQUISITION CORP (HAIAF) has negative shareholder equity of -$1.4M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is HEALTHCARE AI ACQUISITION CORP's Piotroski F-Score?

HEALTHCARE AI ACQUISITION CORP (HAIAF) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are HEALTHCARE AI ACQUISITION CORP's earnings high quality?

HEALTHCARE AI ACQUISITION CORP (HAIAF) has an earnings quality ratio of -7.85x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.